Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2024 Earnings Call Transcript

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2024 Earnings Call Transcript November 7, 2024

Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-1.22.

Operator: Good day, everyone, and welcome to today’s Arcturus Therapeutics Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator...